...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: OTC Expert & Grey Market Restrictions

Whatever there is ongoing with ZHCLF, the stock already traded 226, 230 shares in the first 5 minutes of trading this morning, thus far.

 

Koo

Share
New Message
Please login to post a reply